↓ Skip to main content

Methylene blue for intractable pain from oral mucositis related to cancer treatment: a randomized phase 2 clinical trial

Overview of attention for article published in BMC Medicine, November 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

twitter
37 X users
facebook
1 Facebook page

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
23 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Methylene blue for intractable pain from oral mucositis related to cancer treatment: a randomized phase 2 clinical trial
Published in
BMC Medicine, November 2022
DOI 10.1186/s12916-022-02579-8
Pubmed ID
Authors

Carlos J. Roldan, Billy Huh, Juhee Song, Yago Nieto, Joyce Osei, Thomas Chai, Kent Nouri, Lakshmi Koyyalagunta, Eduardo Bruera

X Demographics

X Demographics

The data shown below were collected from the profiles of 37 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 23 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 2 9%
Other 2 9%
Student > Bachelor 2 9%
Student > Master 2 9%
Professor > Associate Professor 2 9%
Other 1 4%
Unknown 12 52%
Readers by discipline Count As %
Medicine and Dentistry 4 17%
Nursing and Health Professions 3 13%
Unspecified 2 9%
Biochemistry, Genetics and Molecular Biology 1 4%
Psychology 1 4%
Other 1 4%
Unknown 11 48%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 24. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 April 2024.
All research outputs
#1,619,010
of 25,822,778 outputs
Outputs from BMC Medicine
#1,139
of 4,098 outputs
Outputs of similar age
#34,453
of 442,605 outputs
Outputs of similar age from BMC Medicine
#28
of 167 outputs
Altmetric has tracked 25,822,778 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,098 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 46.2. This one has gotten more attention than average, scoring higher than 72% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 442,605 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 167 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.